Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Chiabrando C et al. |
Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat. |
1994 |
Prostaglandins |
pmid:7938613
|
Wallén NH et al. |
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. |
1994 |
Br J Clin Pharmacol |
pmid:7946939
|
Pape HC et al. |
Does the reamer type influence the degree of lung dysfunction after femoral nailing following severe trauma? An animal study. |
1994 |
J Orthop Trauma |
pmid:7965291
|
Kitano A et al. |
Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. |
1994 |
Headache |
pmid:8002323
|
Larsson PT et al. |
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. |
1994 |
Circulation |
pmid:8181117
|
Djurup R et al. |
Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. |
1993 |
Clin. Chem. |
pmid:8252718
|
Smith SR et al. |
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. |
1993 |
Transplantation |
pmid:8279014
|
van Kooten F et al. |
Evidence for episodic platelet activation in acute ischemic stroke. |
1994 |
Stroke |
pmid:8303731
|
Foegh ML et al. |
Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. |
1994 |
J. Intern. Med. |
pmid:8308478
|
Chiabrando C et al. |
Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. |
1993 |
Prostaglandins |
pmid:8321910
|
Takasaki W et al. |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. |
1993 |
Thromb. Res. |
pmid:8367836
|
Schiff E et al. |
Reduction of thromboxane A2 synthesis in pregnancy by polyunsaturated fatty acid supplements. |
1993 |
Am. J. Obstet. Gynecol. |
pmid:8420313
|
Van Assche FA et al. |
Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia. |
1993 |
Am. J. Obstet. Gynecol. |
pmid:8420355
|
Koudstaal PJ et al. |
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. |
1993 |
Stroke |
pmid:8421822
|
Foulon I et al. |
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. |
1993 |
Arterioscler. Thromb. |
pmid:8443146
|
Chen HI et al. |
Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats. |
1993 |
Acta Physiol. Scand. |
pmid:8452036
|
Ciabattoni G et al. |
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. |
1993 |
J. Am. Coll. Cardiol. |
pmid:8473644
|
Yasu T et al. |
Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. |
1993 |
Am. J. Cardiol. |
pmid:8480641
|
Yamanaka S et al. |
11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. |
1993 |
Prostaglandins |
pmid:8484010
|